Journal article · 2019 · Open access

Blocking α 4 β 7 integrin binding to SIV does not improve virologic control

Nami Iwamoto, Rosemarie D. Mason, Kaimei Song, Jason Gorman, Hugh C. Welles, James A. Arthos, Claudia Cicala, Susie Min, Hannah A. D. King, Aaron J. Belli, Keith A. Reimann, Kathryn E. Foulds and 4 more

Science, 365(6457), 1033–1036 · Published 5 September 2019 · DOI 10.1126/science.aaw7765

Open full textView at the publisherCite this paper

In brief

“Blocking α 4 β 7 integrin binding to SIV does not improve virologic control” is a 2019 journal article by Nami Iwamoto and 15 co-authors, published in Science. OpenAlex counts 39 citations as of 19 November 2026. It is open access: the full text is free to read at PubMed Central.

Citations
39
Most cited in
2021 (10)
Field-weighted impact
2.68
References
22
Authors
16

Abstract

An antibody is not the antidote An HIV therapeutic that would give long-term remission without sustained antiretroviral therapy (ART) is a long-term goal. Byrareddy et al. [ Science 354 , 197 (2016)] reported that treating simian immunodeficiency virus (SIV)–positive macaques with an antibody against integrin α 4 β 7 during and after ART results in sustained virologic control after stopping all treatment. Three studies in this issue question the reproducibility of that result. Di Mascio et al. sequenced the virus used in the 2016 study and found that it was a variant with a stop codon in the nef gene rather than a wild-type virus. Abbink et al. used the same antibody for α 4 β 7 as before but tested control of a more commonly used pathogenic virus. Iwamato et al. used the same nef -stop virus as in the earlier paper but combined the antibody against the integrin with an antibody against the SIV envelope glycoprotein, which also blocks viral binding of the integrin. None of these three new studies found that treating with the antibody had any effect on virologic control after stopping ART treatment. Science , this issue p. 1025 , p. 1029 , p. 1033

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Iwamoto, N., Mason, R. D., Song, K., Gorman, J., Welles, H. C., Arthos, J. A., Cicala, C., Min, S., King, H. A. D., Belli, A. J., Reimann, K. A., Foulds, K. E., Kwong, P. D., Lifson, J. D., Keele, B. F., & Roederer, M. (2019). Blocking α 4 β 7 integrin binding to SIV does not improve virologic control. Science, 365(6457), 1033–1036. https://doi.org/10.1126/science.aaw7765

MLA 9

Iwamoto, Nami, et al. “Blocking α 4 β 7 integrin binding to SIV does not improve virologic control.” Science, vol. 365, no. 6457, 2019, pp. 1033–1036. https://doi.org/10.1126/science.aaw7765.

Chicago

Iwamoto, Nami, Rosemarie D. Mason, Kaimei Song, Jason Gorman, Hugh C. Welles, James A. Arthos, Claudia Cicala, et al. 2019. “Blocking α 4 β 7 integrin binding to SIV does not improve virologic control.” Science 365 (6457): 1033–1036. https://doi.org/10.1126/science.aaw7765.

Harvard

Iwamoto, N. et al. (2019) ‘Blocking α 4 β 7 integrin binding to SIV does not improve virologic control’, Science, 365(6457), pp. 1033–1036. doi:10.1126/science.aaw7765.

IEEE

N. Iwamoto et al., “Blocking α 4 β 7 integrin binding to SIV does not improve virologic control,” Science, vol. 365, no. 6457, pp. 1033–1036, 2019, doi: 10.1126/science.aaw7765.

BibTeX

@article{iwamoto2019blocking,
  title     = {{Blocking α 4 β 7 integrin binding to SIV does not improve virologic control}},
  author    = {Iwamoto, Nami and Mason, Rosemarie D. and Song, Kaimei and Gorman, Jason and Welles, Hugh C. and Arthos, James A. and Cicala, Claudia and Min, Susie and King, Hannah A. D. and Belli, Aaron J. and Reimann, Keith A. and Foulds, Kathryn E. and Kwong, Peter D. and Lifson, Jeffrey D. and Keele, Brandon F. and Roederer, Mario},
  journal   = {Science},
  year      = {2019},
  volume    = {365},
  number    = {6457},
  pages     = {1033--1036},
  doi       = {10.1126/science.aaw7765},
  url       = {https://doi.org/10.1126/science.aaw7765}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
201955
202099
20211010
202222
202322
202433
202566
202611

Its field-weighted citation impact is 2.68: it has been cited 2.68 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • alpha4beta7 integrin
  • simian immunodeficiency virus
  • antibody therapy
  • viral variants
  • envelope glycoprotein
  • integrin blockade
  • antiretroviral therapy withdrawal
  • macaque model

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Iwamoto, N., Mason, R. D., Song, K., Gorman, J., Welles, H. C., Arthos, J. A., Cicala, C., Min, S., King, H. A. D., Belli, A. J., Reimann, K. A., Foulds, K. E., Kwong, P. D., Lifson, J. D., Keele, B. F., & Roederer, M. (2019). Blocking α 4 β 7 integrin binding to SIV does not improve virologic control. Science, 365(6457), 1033–1036. https://doi.org/10.1126/science.aaw7765

How many times has this paper been cited?

39 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Nami Iwamoto, Rosemarie D. Mason, Kaimei Song, Jason Gorman, Hugh C. Welles, James A. Arthos, Claudia Cicala, Susie Min, Hannah A. D. King, Aaron J. Belli, Keith A. Reimann, Kathryn E. Foulds and 4 more.

What is the DOI of this paper?

10.1126/science.aaw7765, permanently at https://doi.org/10.1126/science.aaw7765. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.